Target intelligence / Profile preview

Cullin-associated NEDD8-dissociated protein 2 (CAND2)

Target
CAND2
Molecular classification
Other (SCF ubiquitin ligase assembly factor), Protein exchange factor, Regulator of E3 ubiquitin ligase complexes
01

Overview

Cullin-associated NEDD8-dissociated protein 2 (CAND2) is a regulatory protein predominantly found in mammals, with tissue enrichment in cardiac and skeletal muscle cells. It is a homolog of CAND1 and functions by binding to Cullin-1, facilitating the dynamic exchange of F-box proteins in the SCF (SKP1–CUL1–F-box protein) E3 ubiquitin ligase complexes, thereby promoting selective protein degradation within the cell. CAND2 is less globally efficient than CAND1 but is selectively important in specific tissues. Its disruption modifies the turnover of hundreds of proteins, impacting cellular and organismal health, with genetic links to heart disease and metabolic disorders. The protein’s molecular mechanism, expression patterns, and disease associations suggest roles as a risk modifier and candidate biomarker, but as of now there are no approved drugs directly targeting CAND2.

Other names
CAND2Cullin-associated NEDD8-dissociated protein 2KIAA0667TIP120BTBP-interacting protein 120BTp120bEpididymis tissue protein Li 169p120 CAND2
02

Mechanism of action

Not applicable; no existing drugs known to directly target CAND2. Hypothetically, future molecules could inhibit or enhance CAND2-mediated SCF assembly, thus affecting ubiquitin-dependent protein degradation and downstream cellular signaling

03

Biological functions

SCF complex assembly (Skp1, Cullin-1, F-box protein E3 ubiquitin ligase)Exchange of substrate-recognition subunits (F-box proteins) in SCF complexesProtein ubiquitination and regulated protein degradationModulation of DNA-templated transcription (predicted)Cellular protein turnover
04

Disease associations

Cardiovascular disease (atrial fibrillation, adverse cardiac remodeling)ObesityClubfootProstatic adenoma
05

Safety considerations

No notable safety concerns described for targeting CAND2 itself; however, modulating the SCF ubiquitin ligase pathway may affect cell cycle, protein turnover, and risk unintended effects on cell viability and disease processesSince knockout of CAND2 is not lethal (unlike CAND1), but is associated with altered protein degradation and disease risk, chronic modulation might affect muscle and heart functions
06

Biomarkers

CAND2 expression has potential as a biomarker for risk stratification in cardiovascular conditions such as atrial fibrillation and adverse cardiac remodeling, according to genetic and omics studies

Beyond the preview

Go deeper on Cullin-associated NEDD8-dissociated protein 2 (CAND2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cullin-associated NEDD8-dissociated protein 2 (CAND2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call